跳至主要内容
临床试验/CTRI/2021/05/033866
CTRI/2021/05/033866尚未招募未知

A real world evidence based clinical management of heterogenous group of cancer patients in chemotherapy induced Adverse Drug Reactions (ADRs) by tho use of Rasayana Therapy-a prospective study

Rasayu Cancer Clinic Pune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1 Biopsy confirmed Diagnosed cases of carcinoma at any stage
  • 2 Have taken at least three cycle of Chemotherapy without Rasayana therapy and willing to take further cycles with Rasayana therapy or
  • 3 Patients have completed chemotherapy earlier and now willing to take chemotherapy and Rasayana therapy simultaneously
  • 4 Patient who are Advised to take same chemotherapy along with Rasayana
  • 5 Patients with intact cognitive functions who can recollect the intensity of adverse events or earlier chemotherapy
  • 6 Patients who have planned to Take CT cycle at least 15 days after initiation of Rasayana therapy

排除标准

  • Exclusion criteria
  • 1.Patients taking radiotherapy
  • 2. Patients taking another alternative therapy

研究者

发起方
Rasayu Cancer Clinic Pune

相似试验